v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net income $ 102,586 $ 125,044
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 164,149 142,439
Deferred income taxes 12,646 6,567
Provision for credit losses 1,021 1,405
Amortization of debt issuance costs 3,158 2,745
Employee stock-based compensation costs 7,841 8,530
Pension and postretirement benefit plan net periodic benefit cost 1,392 1,074
Unrealized gains on investments (1,351) (2,187)
Gains on sales of assets (5,272) (15,644)
Gains on bargain purchases (235) (3,547)
Equity in earnings of unconsolidated affiliates (766) (227)
Changes in current assets and liabilities, net of acquisitions:    
Receivables (346,179) (267,478)
Inventories (22,548) (15,277)
Other current assets 16,404 3,742
Accounts payable 97,331 72,530
Other current liabilities 30,545 16,704
Pension and postretirement benefit plan contributions (421) (437)
Other noncurrent changes 584 6,600
Net cash provided by operating activities 60,885 82,583
Investing activities:    
Capital expenditures (208,574) (290,327)
Acquisitions, net of cash acquired (185,725) (527,979)
Net proceeds from sale or disposition of property and other 10,401 38,273
Investments (2,993) (2,986)
Net cash used in investing activities (386,891) (783,019)
Financing activities:    
Issuance of long-term debt 400,000 520,000
Repayment of long-term debt (10,835) (5,878)
Debt issuance costs (3,835) (11,070)
Tax withholding on stock-based compensation (5,425) (2,653)
Net cash provided by financing activities 379,905 500,399
Increase (decrease) in cash, cash equivalents and restricted cash 53,899 (200,037)
Cash, cash equivalents and restricted cash -- beginning of year 123,418 281,134
Cash, cash equivalents and restricted cash -- end of period $ 177,317 $ 81,097